Cell and Gene Therapy Manufacturing Market to Achieve a Valuation of USD 8.8 billion by 2031| Analysis by Transparency Market Research

Scientific advancements and a growing understanding of cellular & genetic mechanisms are driving the global cell and gene therapy manufacturing market

Wilmington, Delaware, United States, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global cell and gene therapy manufacturing market is projected to flourish at a CAGR of 25.2% from 2023 to 2031. As per the report published by TMR, a valuation of US$ 8.8 billion is anticipated for the market in 2031. As of 2023, the demand for cell and gene therapy manufacturing is expected to close at US$ 1.4 billion.

Substantial investments from both the private sector and government agencies have provided a significant boost to the cell and gene therapy manufacturing market.

Global cell and gene therapy manufacturing market demand is poised for sustained expansion as chronic diseases continue to affect a larger proportion of the global population.

Innovations in gene editing technologies, such as CRISPR-Cas9 and TALEN, have made it easier to develop gene therapies. These technologies have accelerated the development of new treatments and increased the potential market size.

Download Sample of this Research Report@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85808

The successful clinical trials and approvals of cell and gene therapies for various diseases have bolstered investor confidence and encouraged further research and development in the field.

Key Takeaways from the Market Study

  • As of 2022, the cell and gene therapy manufacturing  market was valued at US$ 1.1 billion
  • Based on indication, the oncology segment is poised to dominate the global market during the forecast period.
  • In terms of product type, the consumables segment accounted for the largest global cell and gene therapy manufacturing market share in 2022. 
  • In terms of end-users, the pharmaceutical & biotechnology companies segment is projected to account for the leading share of the global market during the forecast period.

Cell and Gene Therapy Manufacturing Market – Regional Analysis

  • North America dominated the global industry in 2022. The region is home to a robust and well-established pharmaceutical and biotechnology industry. The rise in the prevalence of chronic diseases has amplified the demand for advanced treatment options, driving investment and research in cell and gene therapies. Additionally, the region's well-established healthcare infrastructure and regulatory framework provide a conducive environment for developing and commercializing manufacturing processes.
  • Asia Pacific is expected to proliferate during the forecast period. This can be ascribed to expanding healthcare infrastructure and increasing research & development investment in the region Favorable regulatory policies and streamlined approval processes in countries such as China, Japan, facilitate quicker market entry for cell and gene therapy products. A large population base and rise in the prevalence of chronic diseases in the region drive demand for advanced treatment options, boosting the market's expansion.

Key Developments in Cell and Gene Therapy Manufacturing Market

  • Lonza is a global contract development and manufacturing organization (CDMO) with a significant presence in the cell and gene therapy space. They provide services for cell and gene therapy manufacturing and have been involved in the production of various therapies.
  • Thermo Fisher is a leading life sciences company that offers a range of products and services for cell and gene therapy manufacturing, including bioprocessing equipment, analytical instruments, and gene editing technologies.
  • Catalent is another CDMO that offers end-to-end solutions for cell and gene therapy manufacturing. They have expertise in process development, analytical services, and clinical and commercial manufacturing

Have Any Query? Ask our Experts@ https://www.transparencymarketresearch.com/sample/sample.php?flag=ASK&rep_id=85808

Competitive Landscape

The global cell and gene therapy manufacturing market is fragmented, with the presence of large a number of players. An increase in investment in R&D and merger & acquisition are the key strategies leading companies adopt.

  • Lonza Group Ltd.
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Danaher Corporation
  • Bio-Techne Corporation
  • Sartorius AG (Sartorius Stedim Biotech S.A.)
  • Bio-Rad Laboratories, Inc.
  • Becton, Dickinson and Company
  • Fresenius Medical Care AG & Co. KGaA
  • MaxCyte
  • Getinge AB
  • GE HealthCare

Cell and Gene Therapy Manufacturing Market – Key Segments

Therapy Type

  • Cell Therapy
    • Allogeneic
      • Mesenchymal Stem Cells
      • T-cells
      • Induced Pluripotent Stem Cells
      • Natural Killer Cells
      • Hematopoietic Stem Cells
      • Other Allogeneic Cells
    • Autologous
      • T-cells
      • Hematopoietic Stem Cells
      • Mesenchymal Stem Cells
      • Natural Killer Cells
      • Other Autologous Cells
  • Gene Therapy
      • Viral Vector
          • Lentiviral Vector
          • Adeno- associated Virus Vectors
          • Other Viral Vectors
      • Non-viral Vector
          • Electroporation
          • Other Non-viral Vectors

Product Type

  • Consumables
  • Software & Systems
  • Equipment
  • Cell processing Equipment
  • Single-use Equipment
  • Other Equipment


  • Cell Culture & Expansion
  • Viral Vector Production
  • Cell Sorting & Purification
  • Gene Editing
  • Others


  • Oncology Disease
  • Cardiovascular Disease
  • Orthopedic Disease
  • Infectious Disease
  • Other Diseases (Ophthalmology, CNS Diseases, etc.)


  • Pharmaceutical & Biotechnology Companies
  • Contract Manufacturing Organizations (CMOs)


  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Place an Order Copy of the Report@ https://www.transparencymarketresearch.com/checkout.php?rep_id=85808&ltype=S

Browse More Reports by TMR:

Gene Synthesis Market- The global gene synthesis market stood at US$ 1.6 Billion in 2023 and the industry is expected to reach US$ 14.2 Billion by 2033. The global industry is projected to grow at a CAGR of 23.6% between 2023 and 2033.

Stem Cells Market- The global stem cells market stood at US$ 11.7 billion in 2020 and the global market is projected to reach US$ 25.6 billion by 2028. The global industry is anticipated to expand at a CAGR of 10.4% between 2021 and 2028.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Nikhil Sawlani
Transparency Market Research Inc.
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com   
Blog: https://tmrblog.com   

Email: sales@transparencymarketresearch.com